<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0047">
 <label>47</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Ranson</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Middleton</surname>
    <given-names>MR</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bridgewater</surname>
    <given-names>J</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Lomeguatrib, a potent inhibitor of 
   <italic>O6</italic>-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors
  </article-title>. 
  <source>Clin Cancer Res</source>
  <year>2006</year>;
  <volume>12</volume>:
  <fpage>1577</fpage>–
  <lpage>84</lpage>.
  <pub-id pub-id-type="pmid">16533784</pub-id>
 </mixed-citation>
</ref>
